학술논문
A Phase II study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA)
Document Type
Article
Author
Stewart, G.D.; Welsh, S.J.; Ursprung, S.; Gallagher, F.A.; Jones, J.O.; Mitchell, T.J.; Warren, A.Y.; Eisen, T.; Mendichovszky, I.A.; Priest, A.N.; Wallis, L.; Cross, R.; Burge, S.W.; George, A.; Klatte, T.; Rossi, S.; Massie, C.; Anand, S.; Haddow, T.; Dodd, M.; Deng, W.; Martin, E.; Howden, P.; Wenlock, S.; Sala, E.; Fife, K.; Riddick, A.C.P.; Matakidou, A.; Caasi, C.; Watson, J.; Aho, T.F.; Armitage, J.N.; Shields, J.; Smith, C.G.; Bex, A.; Boleti, E.; Mumtaz, F.; Powles, T.; Pejnovic, A.; Tincey, S.; Grant, L.; Carruthers, J.; Welsh, M.; Riddle, K.; Hopcroft, L.E.M.; Couper, N.; Hopcroft, L.E.M.; Hill, R.; Hamid, A.; Nuttall, M.; Willsher, L.; Barnett, C.; Laird, A.; Leung, S.; Malik, J.; Symeonides, S.; Ho, L.; Baxter, J.; Leslie, S.; McLaren, D.; Brush, J.; O’Donnell, M.; Oades, G.; Venugopal, B.; Griffin, A.; Orr, R.; Cowan, C.; Jones, R.J.; Nicol, D.; Larkin, J.; Fielding, A.
Source
In: British Journal of Cancer . (British Journal of Cancer, 2022)
Subject
Language
English
ISSN
15321827
00070920
00070920